Efficacy of the Voluntary Pricing and Access Scheme (VPAS)
Elizabeth Woodeson, Director of Medicines and Pharmacy, Department of Health and Social Care, UK Government, told us the UK Government believed "VPAS is an effective mechanism for capping the rate of growth in branded medicine spend, which is, by far, the bulk of expenditure on medicines"iHealth and Sport Committee, Official Report, 21 January 2020, Col 2.